Thanks to new advancements in science, the emerging health benefits of HMOs can be leveraged to support consumers throughout life. Offering the widest portfolio of commercially available HMOs to more than 165 countries worldwide, dsm-firmenich’s science-backed GlyCare™ HMOs have an extensive history in the market. dsm-firmenich’s broad portfolio of high-quality products, customized solutions and expert services – supported by our fully integrated and dedicated HMO production site – make us your end-to-end partner in bringing purpose-led HMO innovation to the early life nutrition and dietary supplement markets.
The HMO donation program was established in 2010 to expand the knowledge and support the research in HMOs. All healthcare professionals, researchers and academics interested in the field of Human Milk Oligosaccharide research can apply for HMO donation.
To date, dsm-firmenich has supported over 100 research projects through the donation program. These projects span 55 different research centers all around the globe. The donation program accesses dsm-firmenich’s HMO library, which contains nearly 20 different HMO structures and mixtures.
Our team has developed analytical standards for HMOs for more than 10 years. We have gained extensive experience in production of HMOs with chemical and enzymatical synthesis and fermentation technology as part of our development of commercial HMOs. The analytical standards have had key importance for our ability to quality test and control our own products.
dsm-firmenich is spearheading innovation in the field of oligosaccharides with the widest range of commercially available HMOs. As a reliable end-to-end, innovative and purpose-led provider, dsm-firmenich offers a broad portfolio of science-backed products and customized solutions powered by expert services uniquely aimed at supporting your entire product life cycle, from concept to consumer. This takes more than ingredients, it takes a partner.